These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3469840)

  • 1. Vaginal PGE2 and intraamniotic PGF2 alpha for the termination of second trimester pregnancy.
    Farmakides G; Schulman H; Fayemi A; Fleischer A; Mitchell J; Blattner P
    Acta Chir Hung; 1986; 27(3):137-42. PubMed ID: 3469840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of two types of prostaglandins for abortion during the second trimester.
    Rettenmaier MA; Hanson FW
    Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midtrimester abortion with urea, prostaglandin F2alpha, laminaria, and oxytocin. A new regimen.
    Wilson WB
    Obstet Gynecol; 1978 Jun; 51(6):699-701. PubMed ID: 662249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
    Lebed JP; Rubin A; Millman AE
    Obstet Gynecol; 1980 Jul; 56(1):90-6. PubMed ID: 7383493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination.
    Owen J; Hauth JC
    Obstet Gynecol; 1996 Jul; 88(1):110-3. PubMed ID: 8684741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraamniotic prostaglandin F2 alpha for pregnancy termination in the second and early third trimesters of pregnancy.
    Lipitz S; Grisaru D; Libshiz A; Rotstein Z; Schiff E; Lidor A; Achiron R
    J Reprod Med; 1997 Apr; 42(4):235-8. PubMed ID: 9131497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Termination of pregnancy in the 2nd trimester using intra-amniotic administration of prostaglandins].
    Krofta L; Calda P; Zizka Z; Parízek A; Hrusková H; Kapras J
    Ceska Gynekol; 1998 Oct; 63(5):414-7. PubMed ID: 9818502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intra-amniotic (15S)-15-methyl-PGF2 alpha and intravaginal prostaglandin E2 for second-trimester uterine evacuation.
    Perry KG; Roberts WE; Martin RW; Magann EF; Sullivan DL; Morrison JC
    J Perinatol; 1998; 18(1):24-7. PubMed ID: 9527940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Induction of therapeutic abortion by intra-amniotic and intravenous administration of prostaglandin F2-alpha in the second trimester of pregnancy].
    Otoka A; Otoka K
    Wiad Lek; 1982 Sep; 35(15-16):969-72. PubMed ID: 6959421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced second trimester abortion by extra-amniotic prostaglandin infusion in patients with a cesarean scar: is it safe?
    Shapira S; Goldberger S; Beyth Y; Fejgin MD
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):511-4. PubMed ID: 10376860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-trimester pregnancy termination: comparison of three different methods.
    Makhlouf AM; Al-Hussaini TK; Habib DM; Makarem MH
    J Obstet Gynaecol; 2003 Jul; 23(4):407-11. PubMed ID: 12881083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abortion-inducing effect of prostaglandin F2-alpha in the mid-trimester of pregnancy.
    Pajor A; Zsolnai B
    Acta Chir Hung; 1984; 25(4):229-38. PubMed ID: 6596819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midtrimester pregnancy termination for fetal malformations. Use of intravaginal prostaglandin E2.
    Hagar DL; Valley MT; Rayburn WF; Carey JC
    J Reprod Med; 1997 Aug; 42(8):497-500. PubMed ID: 9284011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midtrimester induction of abortion: comparison of extraovular prostaglandin E2 and intra-amniotic prostaglandin F2 alpha.
    Lurie S; Katz Z; Insler V
    Contraception; 1993 May; 47(5):475-81. PubMed ID: 8513674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Termination of pregnancy by extraamniotic prostaglandins and the synergistic action of oxytocin.
    Embrey MP; Hillier K; Mahendran P
    Adv Biosci; 1973; 9():507-13. PubMed ID: 4805861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induced abortion after the 12th week of pregnancy. II].
    Blacquière JF; Treffers PE
    Ned Tijdschr Geneeskd; 1979 Jun; 123(26):1110-4. PubMed ID: 460461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostaglandins for the termination of pathological pregnancies in the 2d trimester].
    Gruber W
    Wien Klin Wochenschr; 1982 Oct; 94(20):558-60. PubMed ID: 6963074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
    Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
    Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic abortions in the second trimestre of pregnancy with prostaglandine gel (author's transl)].
    Heinzl S
    Geburtshilfe Frauenheilkd; 1978 Mar; 38(3):220-6. PubMed ID: 640366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.